- Home
- IRD vs NSTS Comparison
IRD vs NSTS Comparison
Compare IRD & NSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRD
- NSTS
- Stock Information
- Founded
- IRD 2018
- NSTS 1921
- Country
- IRD United States
- NSTS United States
- Employees
- IRD N/A
- NSTS N/A
- Industry
- IRD
- NSTS Savings Institutions
- Sector
- IRD
- NSTS Finance
- Exchange
- IRD NYSE
- NSTS Nasdaq
- Market Cap
- IRD 59.1M
- NSTS 65.5M
- IPO Year
- IRD N/A
- NSTS N/A
- Fundamental
- Price
- IRD $1.18
- NSTS $12.05
- Analyst Decision
- IRD Strong Buy
- NSTS
- Analyst Count
- IRD 3
- NSTS 0
- Target Price
- IRD $6.33
- NSTS N/A
- AVG Volume (30 Days)
- IRD 295.4K
- NSTS 3.1K
- Earning Date
- IRD 08-15-2025
- NSTS 08-08-2025
- Dividend Yield
- IRD N/A
- NSTS N/A
- EPS Growth
- IRD N/A
- NSTS N/A
- EPS
- IRD N/A
- NSTS N/A
- Revenue
- IRD $13,651,000.00
- NSTS $9,115,000.00
- Revenue This Year
- IRD $51.41
- NSTS N/A
- Revenue Next Year
- IRD $68.84
- NSTS N/A
- P/E Ratio
- IRD N/A
- NSTS N/A
- Revenue Growth
- IRD N/A
- NSTS 78.72
- 52 Week Low
- IRD $0.65
- NSTS $9.37
- 52 Week High
- IRD $2.09
- NSTS $13.32
- Technical
- Relative Strength Index (RSI)
- IRD N/A
- NSTS 46.01
- Support Level
- IRD N/A
- NSTS $12.02
- Resistance Level
- IRD N/A
- NSTS $12.39
- Average True Range (ATR)
- IRD 0.00
- NSTS 0.14
- MACD
- IRD 0.00
- NSTS -0.01
- Stochastic Oscillator
- IRD 0.00
- NSTS 51.92
About IRD OPUS GENETICS INC
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.